AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics (Babson), a transformative medical technology company, is improving the way the public receives diagnostic blood testing. According to the CDC, 70% ...

Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline ...

Please provide your email address to receive an email when new articles are posted on . A kidney disease panel for 382 genes yielded a high success rate and was effective in identifying monogenic ...

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets We used data from the 2017 National Survey ...